Skip to main content
. 2019 Feb 27;27(e1):e30–e35. doi: 10.1136/ejhpharm-2018-001713

Table 3.

Pharmacokinetic parameters for meropenem and piperacillin obtained from Css determinations

Css (mg/l)
Mean±SD
P value (ANOVA) CL (ml/kg.min)
Mean±SD
P value (ANOVA) AUC (μg.h/ml)
Mean±SD
P value
(ANOVA)
Meropenem (n=Css determinations)
 (A) Dose adjustment not required and no CRRT (n=26) 20.7±10.3 <0.0001 3.2±1.6 <0.0001* 74.6±37.9 <0.0001
 (B) Dose adjustment required and no CRRT (n=6) 65.5±25.4 0.8±0.3 234.3±91.4
 (C) With CRRT (n=9) 39.8±16.4 1.18±0.3 139.8±59.1
 All cases (n=41) 30.8±21.4 2.43±1.7 110.8±76.9
Piperacillin
 (A) Dose adjustment not required and no CRRT (n=63) 72.5±46.8 <0.0001† 3.8±2.6 <0.0001† 261.0±168.4 <0.0001†
 (B) Dose adjustment required and no CRRT (n=24) 138.6±44.5 1.1±0.5 499.1±160.1
 (C) With CRRT (n=40) 138.4±57.9 1.2±0.6 498.2±208.6
 All cases (n=127) 108.8±59.0 2,5±2.0 380.0±212.5

*Differences not statistically significant between groups B and C.

†Differences not statistically significant between groups B and C.

AUC, area under the curve; CL, clearance; CRRT, continuous renal replacement therapy; Css, serum concentration at steady state.